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Seroprevalence of Toxoplasma 
gondii IgG antibody in 
HIV/AIDS-infected individuals 
in Maputo, Mozambique
Soroprevalência de IgG 
anti-Toxoplasma gondii em pessoas 
infectadas pelo HIV/Aids em 
Maputo, Moçambique
ABSTRACT
OBJECTIVE: To analyze the prevalence of IgG antibodies to Toxoplasma 
gondii in patients infected with HIV/AIDS and the association of demographic 
and social variables.
METHODS: Descriptive cross-sectional study that included the analysis of 
sociodemographic data and laboratory findings of 200 patients infected with 
HIV/AIDS treated in a laboratory unit in Maputo, Mozambique, in 2010. 
Individual data for all participants were collected with a self-administered 
questionnaire. Plasma samples were tested for IgG testing of anti-T. gondii 
using hemagglutination for the analysis of antibodies.
RESULTS: The seroprevalence of IgG anti-T. gondii was 46.0% 
(95%CI 39.2;52.9), 39.3% (95%CI 29.5;50.0) in men and 50.9% (95%CI 
41.9;59.8) in women, with no difference between sex (OR 1.30; 95%CI 
0.95;1.77; p = 0.12). Ages ranged from 10 to 60 years, with a higher 
prevalence of infection in older age groups, but with no significant difference 
between them. Regularly consuming cattle meat (OR 1.74; 95%CI 1.04;2.89, 
p = 0.05), breeding cats/dogs (OR 6.18; 95%CI 3.60;10.62, p < 0.000) and 
having regular contact with soil (OR 3.38; 95%CI 2.19;5.21; p < 0.000) 
were significantly associated with risk of latent infection.
CONCLUSIONS: Toxoplasmosis is an infection with high prevalence 
in Mozambique. Cultural and behavioral aspects increase the risk. 
Toxoplasmosis can be responsible in our environment by the great burden 
of morbidity and mortality associated with meningoencephalic injuries in 
patients with HIV/AIDS.
DESCRIPTORS: Toxoplasmosis, epidemiology. AIDS-Related 
Opportunistic Infections. HIV Infections, epidemiology. 
Seroepidemiologic Studies.
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Infection with Toxoplasma gondii is common all 
over the world, making it one of the most common 
infections in humans.13,18,21 Although the evolution of 
primary infection is usually with slight signs/symp-
toms, the majority of the human population infected 
remains asymptomatic.3,13 The infection may cause 
an additional burden of morbidity and mortality in 
certain populations,18 as in fetuses of pregnant women 
with acute infection13 and people with compromised 
immunological response.13,14,23
Meningoencephalitis caused by reactivated toxoplas-
mosis is one of the most common neurological oppor-
tunistic infections in patients with HIV infection/AIDS 
and is typically observed in advanced stages of the 
disease.16 The high burden of opportunistic infections 
with T. gondii, especially in immunocompromised 
individuals, mainly verified from 1980s, remains a 
significant public health problem in some countries, 
especially those that have failed to gain universal access 
to highly active antiretroviral therapy (HAART).2,4
RESUMO
OBJETIVO: Avaliar a prevalência de anticorpos IgG anti-Toxoplasma gondii 
em pessoas infectadas pelo HIV/Aids e a associação de variáveis demográficas 
e sociais.
MÉTODOS: Estudo transversal que incluiu a análise de dados sociodemográficos 
e laboratoriais de 200 pessoas infectadas por HIV/Aids, atendidas em unidade 
laboratorial em 2010 na Província de Maputo, Moçambique. Os dados foram 
coletados por meio de questionário autopreenchido por todos os participantes. 
Para a análise de anticorpos, amostras de plasma coletadas foram confirmadas 
para testagem de IgG anti-T. gondii por hemaglutinação.
RESULTADOS: A soroprevalência de IgG anti-T. gondii foi de 46,0% 
(IC95% 39,2;52,9), 39,3% (IC95% 29,5;50,0) em homens e de 50,9% (IC95% 
41,9;59,8) em mulheres, sem diferença entre sexo (OR 1.30; IC95% 0.95;1.77; 
p = 0.12). A idade variou de 10 a 60 anos, com maior prevalência de infecção em 
grupos etários mais idosos, mas sem haver diferença significativa entre eles. Ter 
consumo regular de carne de gado bovino (OR 1,74; IC95% 1,04;2,89, p = 0,05), 
possuir criação de gatos/cães (OR 6,18; IC95% 3,60;10,62, p < 0,000) e ter 
contato regular com a terra (OR 3,38; IC95% 2,19;5,21, p < 0,000) estiveram 
significativamente associados ao risco de infecção latente.
CONCLUSÕES: A infecção por toxoplasmose apresenta alta prevalência na 
população de Moçambique, cujo risco amplia-se pelos aspectos culturais e 
comportamentais. A toxoplasmose pode ser responsável pela grande carga 
de morbimortalidade associada a lesões meningoencefálicas em pessoas com 
HIV/Aids no país.
DESCRITORES: Toxoplasmose, epidemiologia. Infecções Oportunistas 
Relacionadas com a AIDS. Infecções por HIV, epidemiologia. Estudos 
Soroepidemiológicos.
INTRODUCTION
The primary acquisition mode occurs mainly by 
ingestion of raw or undercooked meat of intermediate 
hosts containing viable tissue cysts, or by ingesting 
food and water contaminated with sporulated oocysts 
from the environment, existing and originating in cat 
faeces.18 Close contact between humans and pets, 
especially dogs and cats, can generate situations of 
greater vulnerability to human infection.13,21 There 
is also the possibility of transmission of tachyzoites 
in utero through the placenta or by ingestion of 
tachyzoites in non-pasteurized goat milk. T. gondii 
can also be transmitted by blood components, by solid 
organ transplants.21
Not all possible routes of infection are currently 
epidemiologically important, and sources of infection 
may vary greatly among different ethnic groups and 
geographical locations.13,22 This happens especially in 
environments with characteristics of rural life, which 
increase the risk of infection.8,11,13
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Its incidence has a direct relationship with the preva-
lence of anti-T.gondii in the general population or in 
populations with greater vulnerability.1 The prevalence 
of latent infection with toxoplasmosis is between 30% 
and 60% in most countries, varying widely in different 
regions of the world.5,10,11 Despite its importance, few 
studies on the prevalence have been conducted in 
sub-Saharan Africa.7,9,10,20
There are frequent reports of congenital toxoplas-
mosis or toxoplasmic meningoencephalitis in patients 
with AIDS in Mozambique, but the real situation is 
unknown, with a small number of publications.19 The 
paucity of reliable information on risk factors, main 
means of transmission and of preventative measures 
used, is of concern not only for researchers,9,18,22 but 
for society in general. Considering the scale of AIDS in 
Mozambique6,12,16 and the vulnerability of HIV-infected 
people with toxoplasmosis, there is a clear need for 
further studies on this subject.10,14
This study aimed to analyze the prevalence of IgG 
antibodies to Toxoplasma gondii in patients infected 
by HIV/AIDS and the association of demographic and 
social variables in Maputo, Mozambique.
METHODS
Descriptive cross-sectional study with patients infected 
by HIV/AIDS, who were treated at a reference center 
in Maputo, Mozambique, in the second half of 2010.
The study was conducted in the Maputo Military 
Hospital (HMM) in the city of Maputo. This is a quater-
nary level health unit and a national reference between 
the military hospitals of Mozambique. The HMM, 
with four infirmaries and 220 bed capacity, provides 
medical assistance to the Defense and Security Forces 
and Veterans of the National Liberation Resistance, 
including members of their families. It has an emer-
gency room, operating room services, physical therapy, 
radiology, ophthalmology, dentistry, and a clinical 
laboratory and a special examination room.
The Laboratory of HMM has a samples receiving unit, 
blood collection room, sections serology, microbiology/ 
parasitology, hematology, biochemistry and molecular 
biology (especially designed to assist people living 
with HIV/AIDS).
The target population consisted of all patients infected 
by HIV, aged over 18 years old, male and female, who 
visited the laboratory of HMM, the serology section. 
Recruitment was carried out during routine follow-up 
and during initial visits. Patients who met the inclusion 
criteria and signed consent were recruited consecutively. 
A sample was drawn from this population and a 
cross-sectional survey was conducted. Data collection 
occurred between September and November 2010.
HIV diagnosis is available through voluntary coun-
seling and testing (VCT) centers in Mozambique. Rapid 
tests are used to provide clients with an immediate 
result. HIV positive clients are referred to the Central 
Hospital for assessment and antiretroviral therapy 
(ART) is initiated. Based on the 2010 WHO staging25 
national treatment guidelines, initiation of ART is 
recommended to all adolescents and adults including 
pregnant women with HIV infection and CD4 counts of 
≤ 350 cells/mm3, regardless of the presence or absence 
of clinical symptoms. Those with severe or advanced 
clinical disease (including AIDS) should start ART 
irrespective of their CD4 T-cell count.
The definition of AIDS in Mozambique is the clinical 
diagnosis (presumptive or definitive diagnosis) of any 
stage 4 condition or CD4 T-cell count < 200 cells/mm3 
of blood in a HIV-infected adults.
Two hundred HIV/AIDS seropositive patients agreed 
to participate in the study. Self-administered question-
naires were used with information such as socioeco-
nomic status, race/ethnicity, education level, marital 
status, profession, cohabitation or breeding of cats/dogs 
as pets, contact with the soil in gardens and unprotected 
plantations; consumption of beef or pig and type of 
water consumed. Questions were completed referring 
to patient records from HMM laboratory such as age, 
sex and address.
Blood sample were collected as part of the usual routine 
for evaluating the state of health of the patients and 
sample of the participants were subjected to serological 
assessment for identifying the presence of IgG anti-T. 
gondii. Approximately 2.5 ml of blood by venipuncture 
into vacutainer tube with sterile gel were collected. 
The serum was removed by centrifugation for analysis. 
Approximately 1 ml to 1.5 ml of serum was transferred 
to eppendorf tubes previously identified with the code 
assigned by the investigator during data collection, 
and subsequently frozen at -20oC. This sample was 
maintained on average for ten days until the moment 
the test for determining the level of IgG anti-T. gondii 
was carried out in the microbiology laboratory, in the 
serology section of Maputo Centre Hospital.
The determination of IgG antibodies to T. gondii was 
performed by the serological agglutination visible 
method. The kit trade marked to “Atlas Medical-Toxo 
Latex Kit” (Lot: 81111304, William James House, 
Cowely Rod Cambridge, CB 4 4WX, UK), a latex 
agglutination test for the rapid qualitative detection and 
semi-quantitative serum antibodies to T. gondii was 
used. This commercial kit has a sensitivity of 96.1% and 
specificity of 89.6%. The technique of determination and 
interpretation of the results was performed according to 
the manufacturer’s instructions and recommendations.
The samples were allowed to reach room temperature 
prior to testing. The reagent kits anti-T. gondii were 
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removed from the temperature change of 4°C-8°C and 
maintained also in a room temperature. The identification 
data were strictly checked prior to the execution of the 
test itself.
The presence of visible agglutination after the technique 
procedure is considered a positive result, i.e., the pres-
ence of IgG anti-T. gondii in the patient serum, equivalent 
to a concentration of antibodies equal or greater than 
4 IU/ml, while its absence is negative result.
Tests were performed to define the presence of IgG 
anti-T. gondii of samples from the laboratory of Maputo 
Central Hospital and a private clinic in order to confirm 
the results and to guarantee the quality and validity of 
the reagents used. Ten randomized samples reagents and 
not reagent were tested with another kit test to determine 
anti-T. gondii (Armstrong) and all cases were confirmed.
Data were consolidated into a specific database and 
analyzed using the statistical package SPSS (Statistical 
Package for the Social Sciences) version 11.0. The 
analysis was based on descriptive statistics, with data 
presented into tables and graphs. The estimated prev-
alence of infection with T. gondii was performed with 
the confidence interval. For the univariate analysis, the 
outcome of latent infection by T. gondii was the depen-
dent variable and the association between variables 
(gender, age, regular consumption of meat from cattle, 
breeding of cat/dog and regular contact with soil) was 
verified by chi-square (0.05 significance). The Fisher 
exact test was used for variables with expected frequency 
< 5. The estimates of odds ratios (OR) with 95% confi-
dence intervals (CI) were calculated.
The study protocol was submitted to and approved by 
the Ethics Committee of the Institute of Health Sciences 
of Mozambique and the National Bioethics Committee 
of the Ministry of Health of Mozambique (Protocol nº 
TFCTBLAD036/10).
The execution of this work considered the ethical 
standards and all requirements of confidentiality. 
Participation in this study was voluntary and assured 
by the rendering and prior reading of the terms of 
consent. All study subjects signed the consent form 
that was encoded.
The researcher and the laboratory technicians involved in 
collecting blood samples ensured confidentiality both in 
the process of identifying samples for the study, as well 
as the results that were obtained later.
RESULTS
The majority of the individuals infected with HIV/AIDS 
were women (58.0%) aged between 31 and 40, with no 
evidence of regular consumption of cattle meat (76.0%), 
breeding cat/dog (83.0%) or regular contact with soil 
(73%) (Table).
The prevalence of IgG anti-T.gondii was of 46.0% 
(95%CI 39.2;52.9). Seropositivity was more frequent in 
women and in the 41 to 50 years old age group, although 
not statistically significant (respectively, OR = 1.30; 
95%CI 0.95;1.77; p = 0.12 and OR = 2.33, 95%CI 
0.84;6.44; p = 0.61). Seropositivity was higher in older 
age groups.
Table. Social and demographic characteristics of the 200 cases studied according existence of infection by T. gondii. Maputo, 
Mozambique, 2010.
Variable
Non-reactive T. gondii Reactive T. gondii
Odds ratio 95%CI p
n % n %
Total 108 54.0 92 46.0 – – –
Gender
Male 51 47.2 33 35.9 1 – –
Female 57 52.8 59 64.1 1.60 0.91;2.83 p = 0.11
Age (years)
10 to 20 7 6.5 2 2.2 1 – –
21 to 30 26 24.1 22 23.9 2.06 0.70;6.12 p = 0.28
31 to 40 37 34.3 31 33.7 2.05 0.71;5.95 p = 0.29
41 to 50 26 24.1 28 30.4 2.33 0.84;6.44 p = 0.61
51 to 60 12 11.1 9 9.8 1.93 0.57;6.52 p = 0.42
Regular consumption of cattle meat
No 121 79.6 31 64.6 1 – –
Yes 31 20.4 17 35.4 1.74 1.04;2.89 p = 0.05
Breeding cat/dog
No 151 90.9 15 44.1 1 – –
Yes 15 9.1 19 55.9 6.18 3.60;10.62 p < 0.000
Regular contact with soil
No 122 83.6 24 44.5 1 – –
Yes 24 16.4 30 55.5 3.38 2.19;5.21 p < 0.000
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Breeding cats was the situation most significantly 
associated with the presence of infection (OR = 6.18; 
95%CI 3.60;10.62, p < 0.000), followed by having 
regular contact with soil (OR = 3, 38; 95%CI 2.19;5.21, 
p < 0.000) and regularly consuming cattle meat 
(OR = 1.74; 95%CI 1.04;2.89; p = 0.05) (Table).
DISCUSSION
The estimate of 46.0% prevalence of latent infection 
by T. gondii in the population infected by HIV/AIDS 
treated at a referral center in Maputo, Mozambique, 
is representative of the magnitude of the problem in 
the country.
The relevance of this study is strengthened by the 
lack of studies not only in Mozambique,19 but in the 
African continent as a whole.2,3,9,20,22,23
The prevalence of latent infection by T. gondii found 
in this study was higher than most estimates in other 
studies conducted with HIV/AIDS positive individuals 
in many places around the world, particularly in neigh-
boring countries belonging to sub-Saharan Africa. The 
estimates vary from 4.0% to 8.0% in Zambia, 5.0% to 
17.0% in South Africa, 19.0% in Zimbabwe, 26.0% in 
Angola, 36.5% in Nigeria, 44.0% in Namibia, Uganda 
on 34.0% to 54.0%, 40.0% to 70.0% in Tanzania, 
55.5% Kenya and 93.0% in Ethiopia.1,5,7,10,20-23 In 
some countries in sub-Saharan Africa, particularly 
Mozambique, where the prevalence of HIV/AIDS is 
elevated, epidemiological information on toxoplas-
mosis in the whole population is limited because of the 
difficulties in carrying out laboratory investigations 
in network health services.24
A recent study evaluating the presence of active/recent 
infection by IgM anti-T. gondii revealed a prevalence 
of 31.3% in HIV pregnant patients at the Maputo 
Central Hospital.19 This gives additional information 
to the results of this study about the load associated 
with toxoplasmosis in Mozambique.
Prevalence rates increase with age,13,18,20 consistent 
with the more frequent finding in this study being in 
the 41 to 50 age group, where 51.8% of the 54 cases 
belonging to this group were reactive.
Despite the increased participation of women in this 
study and higher seropositivity in this population, 
there were no differences in relation to gender. Among 
the 116 women’s samples tested, 29.5% were positive. 
This can probably be explained by the significant prev-
alence of HIV infection in this population and higher 
levels of seeking medical care in our reality.6,12,16 This 
extends the vulnerability in this population, including 
the increased risk of vertical transmission not only of 
HIV, but also of T. gondii.4,15
Risk factors in this population reflect the data in the 
literature and the social, economic and cultural context 
of Mozambique.19 Prevalence estimates of latent infec-
tions by T. gondii in HIV-infected patients showed a 
wide variation in the risk factors and ethnicity factors 
including classic factors such as those evaluated in 
this study, in terms of exposure to soil, animals and 
meat intake.8,11,13,14,18,20,22 Findings of non-reactive tests 
for toxoplasmosis in studies addressing geographic 
regions where there are no cats, such as the Pacific 
Islands25 are registered.
Throughout the history of the epidemic of HIV infec-
tion, toxoplasmosis has been one of the most signifi-
cantly opportunistic infections detected in patients 
with AIDS.4 Even in the era after the introduction of 
HAART, it still represents important public health 
problem, especially to vulnerable populations in 
developing and developed countries.2
This study has important implications, considering 
the possibility of reducing morbidity and mortality 
and increased survival in patients infected with 
HIV/AIDS with the adoption and development of 
HAART, both in adults and in children.2,17 Different 
studies indicate changing clinical and epidemiolog-
ical patterns related to neurotoxoplamosis2,7,17 and its 
association with immune reconstitution inflammatory 
syndrome (IRIS).2,15 Together, these findings extend 
the importance of adopting screening routines for T. 
gondii infection in all newly diagnosed cases of HIV 
infection, with follow-up serologic depending on the 
context of risk associated with each individual.
Limitations of this study include the sampling process, 
that may have undersized the real prevalence by tack-
ling patients who have been followed in this reference 
unit in the country. Population which are highly 
vulnerable to both toxoplasmosis and HIV may not 
have been included in the analysis. Even with these 
restrictions, the prevalence is high and significant 
enough to indicate the magnitude of the problem.
The use of single test for assessment of IgG antibodies 
was unable to distinguish accurately from recent to 
chronic or reactivated infections in the studied popu-
lation. It is appropriate to remark on the vulnerability 
of the health public services in Mozambique by finding 
no wide availability of specific reagents to detain 
anti-T.gondii in public clinical laboratories. This was 
made possible by this research, which reaffirms to the 
health authorities the social and economic relevance 
of investments in this sector.
It reinforces the positive impact of prophylaxis2 
to be established in HIV-infected individuals in 
Mozambique with advanced degree of immunodefi-
ciency, given the high rates of morbidity and mortality 
associated. The importance of these findings is even 
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greater in a country with high prevalence and inci-
dence of HIV infection and patterns of high ende-
micity for Toxoplasmosis,
It emphasizes the magnitude of toxoplasmosis in 
the HIV-infected population in Mozambique and 
the urgent need for additional clinical and epidemi-
ological research. The prioritization of research and 
development to address the complex dynamics of 
transmission of toxoplasmosis and its impacts is urgent 
in Africa. Similarly, extending the programs oriented 
towards this population for the serological diagnosis 
and prevention of toxoplasmosis, including pregnant 
women, aiming to reduce the burden of morbidity 
and mortality associated with new infections in 
Mozambique should also be prioritized.
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